← All Conditions ← Urinary Overview

Benign Prostatic Hyperplasia (BPH)

★ CMTO Exam Focus

Benign prostatic hyperplasia is a non-cancerous enlargement of the prostate gland caused by cellular hyperplasia (new cell growth, not hypertrophy) that compresses the prostatic urethra. It is nearly universal in aging men, affecting approximately 50% of men over 60 and 80% of men over 80. The condition results from age-related hormonal shifts involving dihydrotestosterone (DHT) accumulation and changing estrogen-to-testosterone ratios. BPH produces progressive lower urinary tract symptoms (LUTS) that affect quality of life and sleep. Massage therapists should recognize BPH because it is extremely common in older male clients, medication side effects affect treatment safety, and acute urinary retention is a medical emergency.

Populations and Risk Factors

  • Men over age 60 (approximately 50% affected). Men over age 80 (approximately 80% affected)
  • Hormonal shifts associated with aging: DHT accumulation, changing estrogen-to-testosterone ratio
  • Family history of BPH
  • Obesity and metabolic syndrome (associated with larger prostate volume)
  • African American men (higher prevalence and earlier onset)
  • Diabetes mellitus (associated with more severe LUTS)

Causes and Pathophysiology

  • Hormonal mechanism: With aging, intraprostatic levels of dihydrotestosterone (DHT) — a potent androgen converted from testosterone by 5-alpha-reductase — remain high or increase despite declining serum testosterone. The relative increase in estrogen with aging sensitizes prostatic tissue to DHT's growth-promoting effects, stimulating hyperplasia.
  • Mechanical obstruction: The prostate is enclosed by a tough fascial capsule. As hyperplastic tissue accumulates, it can only expand inward, compressing the prostatic urethra. This creates both a static component (physical bulk) and a dynamic component (increased smooth muscle tone in the prostate and bladder neck).
  • Bladder consequence: Chronic outlet obstruction forces the detrusor muscle to hypertrophy to overcome the resistance. Over time, the bladder wall becomes thickened, stiff, and irritable (detrusor overactivity), eventually losing compliance. End-stage BPH can cause urinary retention, hydronephrosis, and renal impairment.
  • BPH is hyperplasia, not hypertrophy: The growth involves new cell formation, not enlargement of existing cells. This is a frequently tested distinction.

Signs and Symptoms

  • Obstructive symptoms: Weak urinary stream, hesitant start, interrupted flow, straining to void, sensation of incomplete emptying, post-voiding dribbling
  • Irritative symptoms: Nocturia (frequent nighttime urination — often the most bothersome symptom), urgency, frequency
  • Typically painless — absence of pain helps distinguish BPH from prostatitis
  • Acute urinary retention: Sudden, complete inability to void despite a full bladder — extremely distressing. Can be triggered by cold medications (anticholinergics, sympathomimetics), alcohol, or prolonged immobility

Red Flags

  • Acute urinary retention: Sudden total inability to void with suprapubic distension — medical emergency; refer to emergency department immediately (risk of bladder rupture and kidney damage)
  • Hard or nodular prostate on DRE: Suggests prostate cancer rather than BPH — urgent urology referral
  • Hematuria (blood in urine): Requires investigation to rule out bladder cancer, kidney stones, or infection
  • Systemic symptoms (fever, chills, perineal pain): Suggest prostatitis or UTI, not uncomplicated BPH

MT Considerations

  • Massage carries no particular risks for men with uncomplicated BPH — treatment is safe as long as secondary complications (UTI, kidney infection) are absent
  • Massage does not reduce prostate size but is a valuable tool for managing associated stress, sleep disturbance (from nocturia), and general wellbeing
  • Bathroom access: Ensure clients have easy and prompt access to the bathroom during sessions — urgency and frequency are common. Interruptions should be handled without embarrassment
  • Medication awareness:
  • Alpha-blockers (tamsulosin, alfuzosin, doxazosin): Relax smooth muscle in the prostate and bladder neck; cause dizziness, orthostatic hypotension, and fatigue — slow table transitions are essential
  • 5-alpha-reductase inhibitors (finasteride, dutasteride): Shrink the prostate over months; can cause sexual dysfunction but have minimal MT-relevant side effects
  • Combination therapy is common
  • Nocturia impact: Clients may be sleep-deprived from frequent nighttime urination — they may fall asleep quickly. Be prepared for shorter alertness windows and drowsy repositioning
  • Emergency recognition: If a client presents with sudden inability to urinate combined with extreme suprapubic distress, refer to the hospital immediately

CMTO Exam Relevance

  • Category: A7 Systemic Conditions — Urinary/Reproductive
  • BPH is hyperplasia (new cells), not hypertrophy (cell enlargement) — a frequently tested distinction
  • BPH is typically painless — pain suggests prostatitis or cancer and requires referral
  • Acute urinary retention is a medical emergency requiring immediate hospital referral
  • DRE showing a hard or nodular surface suggests prostate cancer, not BPH
  • Alpha-blocker medications cause orthostatic hypotension — relevant to safe table transitions

Key Takeaways

  • BPH is nearly universal in aging men and involves hyperplasia (new cell growth), not hypertrophy
  • The condition is typically painless — pain suggests prostatitis or cancer and requires referral
  • Acute urinary retention is a medical emergency requiring immediate hospital referral
  • Massage is safe and supportive for stress management and sleep improvement but does not treat the condition
  • Alpha-blocker medications cause orthostatic hypotension — slow table transitions are essential
  • Ensure bathroom accessibility during sessions for clients with urinary urgency and frequency

Sources

  • Werner, R. (2019). A massage therapist's guide to pathology (7th ed.). Books of Discovery.
  • Porth, C. M. (2014). Essentials of pathophysiology: Concepts of altered states (4th ed.). Lippincott Williams & Wilkins.
  • Rattray, F., & Ludwig, L. (2000). Clinical massage therapy: Understanding, assessing and treating over 70 conditions. Talus Incorporated.
  • Tortora, G. J., & Derrickson, B. H. (2021). Principles of anatomy and physiology (16th ed.). Wiley.